Search Results for 'treatment rbv'

treatment rbv published presentations and documents on DocSlides.

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

by sophia2

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

Current strategies for the management of treatment naïve a

Current strategies for the management of treatment naïve a

by min-jolicoeur

Mark S. Sulkowski, MD. Medical Director, Viral He...

How to optimize treatment of G1 patients?

How to optimize treatment of G1 patients?

by KissesForYou

Prof. G. K. K. Lau 2012. Standard of care (SOC) ...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

by myesha-ticknor

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

by badra

Duke University School of Medicine. Durham, North ...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by webraph

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

by cheryl-pisano

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

Chronic hepatitis C: guidelines for screening and

Chronic hepatitis C: guidelines for screening and

by aaron

treatment. Lisa M. Glass, MD. Clinical Lecturer. ...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by lois-ondreau

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

by celsa-spraggs

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

by test

Out With the Old, In With the New. Current Standa...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

by liane-varnes

Last Updated: February . 21, 2014. Robert G. Gish...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Pharmacometrics and Biostatistics Interactions at the FDA

Pharmacometrics and Biostatistics Interactions at the FDA

by byrne

Jeffry Florian, Ph.D.. Division of Pharmacometrics...

NS5A and polymerase inhibitors

NS5A and polymerase inhibitors

by LoveBug

Mark Sulkowski, MD. Professor of Medicine. Johns H...

Are (exogenous) interferons

Are (exogenous) interferons

by amey

really necessary?. Peter . Ferenci. Medical Univer...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

by karlyn-bohler

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

by ellena-manuel

DSV . placebo. Randomisation*. Partial blind. 1...

by pamella-moone

* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

SMV 12W + PEG-IFN + RBV 24-48W **

SMV 12W + PEG-IFN + RBV 24-48W **

by alexa-scheidler

SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...

by myesha-ticknor

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

by calandra-battersby

+ . Grazoprevir. +/- Ribavirin in . Treatment-N...

Reddy KR. Lancet Infect Dis. 2015;15:27-35

Reddy KR. Lancet Infect Dis. 2015;15:27-35

by natalia-silvester

ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...

by test

PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

by yoshiko-marsland

TURQUOISE-II. Phase 3. . Treatment. Naïve and ...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

by marina-yarberry

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

by pasty-toler

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

by pamella-moone

*. 1:1. Open-label. ≥ 18 years. HCV genotype ...

Treatment of Hepatitis C in patients with

Treatment of Hepatitis C in patients with

by tatyana-admore

thalassaemia. . Where . are we now?. Telaprevir ....

Treatment of Chronic Hepatitis C Virus Infection in Adults

Treatment of Chronic Hepatitis C Virus Infection in Adults

by tracy

www.hivguidelines.org. APRIL 2023. NYSDOH AIDS Ins...

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

by hezekiah

FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...